Updated Jul 16, 2026 · Last SEC filing 2026-06-06
Sarepta Therapeutics, Inc. (SRPT) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-06. 2 Form 8-K material event filings were reported by SRPT in the last 90 days. InsiderAlpha tracks every SRPT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0000873303 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-06 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Wigzell Hans Lennart Rudolf | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Connelly Deirdre P | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Boor Kathryn Jean | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Nicaise Claude | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Barry Richard | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| BEHRENS M KATHLEEN | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Chambers Michael Andrew | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Mayo Stephen | Insider | A — Grant or award | 16.9K | — | — | SEC | |
| Mayo Stephen | Insider | S — Open-market sale | 7.2K | $17.02 | $123K | SEC | |
| Rothfuss Cristin | EVP, General Counsel | F — Tax withholding / forfeiture | 974 | $17.03 | $17K | SEC | |
| Wong Ryan Ho-Yan | Chief Financial Officer | F — Tax withholding / forfeiture | 256 | $17.03 | $4K | SEC | |
| Rodino-Klapac Louise | President, R&D and Tech Ops | F — Tax withholding / forfeiture | 948 | $17.03 | $16K | SEC | |
| Estepan Ian Michael | Chief Operating Officer | F — Tax withholding / forfeiture | 1.1K | $17.03 | $19K | SEC | |
| Wong Ryan Ho-Yan | Chief Financial Officer | F — Tax withholding / forfeiture | 113 | $16.95 | $2K | SEC | |
| Rothfuss Cristin | EVP, General Counsel | F — Tax withholding / forfeiture | 484 | $16.95 | $8K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Sarepta Therapeutics, Inc. (SRPT). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Connelly Deirdre P | 1 | — |
| Barry Richard | 1 | — |
| BEHRENS M KATHLEEN | 1 | — |
| Nicaise Claude | 1 | — |
| Wigzell Hans Lennart Rudolf | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SRPT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live SRPT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.